These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 892292

  • 1. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
    Tsuda H, Miyata Y, Murasaki G, Kinoshita H, Fukushima S.
    Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292
    [No Abstract] [Full Text] [Related]

  • 2. Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.
    Tatematsu M, Miyata Y, Mizutani M, Hananouchi M, Hirose M.
    Gan; 1977 Apr; 68(2):193-202. PubMed ID: 892293
    [Abstract] [Full Text] [Related]

  • 3. A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Becci PJ, Thompson HJ, Grubbs CJ, Moon RC.
    J Natl Cancer Inst; 1979 Jan; 62(1):187-91. PubMed ID: 281573
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A technique for multiparametric analysis of hemodynamic changes in rat urinary bladder during carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Lurie AG, Rippey RM, Conran PB, Tatematsu M, Ito N.
    Gan; 1979 Oct; 70(5):717-8. PubMed ID: 520763
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhancing effect of diethylstilbestrol on urinary bladder carcinogenesis in neonatally castrated male rats.
    Ogiso T, Arai Y, Fukushima S, Nishizuka Y, Ito N.
    Gan; 1982 Dec; 73(6):862-9. PubMed ID: 7160579
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds.
    Hirose M, Fukushima S, Hananouchi M, Shirai T, Ogiso T.
    Gan; 1976 Apr; 67(2):175-89. PubMed ID: 964550
    [Abstract] [Full Text] [Related]

  • 19. Promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in rats.
    Fukushima S, Kurata Y, Tamano S, Inoue K, Ito N.
    Jpn J Cancer Res; 1985 Sep; 76(9):823-7. PubMed ID: 3932280
    [Abstract] [Full Text] [Related]

  • 20. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T, Shirai T, Takahashi S, Mutai M, Fukushima S.
    Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.